Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Aug 28;12:6991–7004. doi: 10.2147/OTT.S214881

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Song et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

SNHG8 regulates the malignant characteristics of Eca109 and TE-1 cells through the miR-411–KPNA2 axis. (A) The transfection efficiency of the miR-411 inhibitor in Eca109 and TE-1 cells was evaluated by RT-qPCR analysis. The NC inhibitor served as the control. *P<0.05 vs NC inhibitor. (B, C) RT-qPCR and Western blotting were respectively utilized to assess miR-411 and KPNA2 protein expression in Eca109 and TE-1 cells following cotransfection with si-SNHG8 and either miR-411 inhibitor or NC inhibitor. *P<0.05 vs si-scramble. ^#P<0.05 vs si-SNHG8+NC inhibitor. (D–G) The proliferation, apoptosis, migration, and invasiveness of the aforementioned cells were evaluated by the CCK-8 assay, flow cytometry, and Transwell migration and invasion assays, respectively. *P<0.05 vs si-scramble. ^#P<0.05 vs si-SNHG8+NC inhibitor.